Eléonore Gravier Selected Research

Neoplasms (Cancer)

1/2014	Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenografts.
1/2013	Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer.
1/2012	Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.
12/2010	A prognostic DNA signature for T1T2 node-negative breast cancer patients.
1/2008	Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eléonore Gravier Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 01/2014 - 01/2008
5	Neoplasms (Cancer) 01/2014 - 01/2008
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 01/2022
1	Inflammation (Inflammations) 12/2023
1	Pruritus (Itching) 12/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2018
1	Triple Negative Breast Neoplasms 01/2013
1	Aneuploidy (Aneuploid) 01/2013
1	Genomic Instability 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Neoplasm Metastasis (Metastasis) 12/2010
1	Carcinoma (Carcinomatosis) 01/2008

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2012
1	Chemokine CCL5IBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	CytokinesIBA 01/2022
1	EmollientsIBA 01/2018
1	enavatuzumabIBA 01/2014
1	TWEAK ReceptorIBA 01/2014
1	Polo-Like Kinase 1IBA 01/2013
1	Annexin A5IBA 01/2013
1	Phenobarbital (Luminal)FDA Link 01/2013
1	CaspasesIBA 01/2013
1	Protein Kinases (Protein Kinase)IBA 01/2013
1	Androgen Receptors (Androgen Receptor)IBA 01/2012
1	Androgen Antagonists (Antiandrogens)IBA 01/2012
1	Tyrosine Kinase InhibitorsIBA 01/2012
1	bicalutamide (Casodex)FDA LinkGeneric 01/2012
1	Flutamide (Eulexin)FDA LinkGeneric 01/2012
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2012
1	AndrogensIBA 01/2012
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 01/2012
1	Hormones (Hormone)IBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 12/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2008
1	human ERBB2 proteinIBA 01/2008

Therapy/Procedure

5	Therapeutics 12/2023 - 01/2008
2	Drug Therapy (Chemotherapy) 01/2014 - 01/2013
1	Hydrotherapy (Whirlpool Bath) 12/2023
1	Castration 01/2012